Percutaneous coronary revascularization of chronic total occlusions (CTOs) is difficult due to the presence of a hard proximal fibrous cap and lack of image guidance. The use of x-ray fluoroscopy alone makes it difficult to identify vessel boundaries and occlusive constituents which would aid the process of revascularization. It also can be difficult to keep a guidewire intraluminal without puncturing the vessel wall. Although several imaging modalities are being developed, a technique for measuring the stiffness of occlusions would facilitate revascularization by helping the process of guidewire selection and placement. In this study, a technique known as static magnetic resonance elastography is explored as a method of determining the compliance of CTOs. A finite element simulation was used to determine the response of an artery to deformation, and displacement images were obtained from an artery phantom using a stimulated echo MR imaging pulse sequence and a pneumatic compression system.

Percutaneous coronary revascularization of chronic total occlusions (CTOs) is difficult due to the presence of a hard proximal fibrous cap and lack of image guidance. The use of x-ray fluoroscopy alone makes it difficult to identify vessel boundaries and occlusive constituents which would aid the process of revascularization. It also can be difficult to keep a guidewire intraluminal without puncturing the vessel wall. Although several imaging modalities are being developed, a technique for measuring the stiffness of occlusions would facilitate revascularization by helping the process of guidewire selection and placement. In this study, a technique known as static magnetic resonance elastography is explored as a method of determining the compliance of CTOs. A finite element simulation was used to determine the response of an artery to deformation, and displacement images were obtained from an artery phantom using a stimulated echo MR imaging pulse sequence and a pneumatic compression system.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2010. / Härtill 4 uppsatser.

Coronary artery disease (CAD) is the leading cause of death worldwide. Treatment with coronary interventions, long-term treatment and life style changes can reduce symptoms and improve prognosis. The aim of this thesis was to investigate aspects of invasive treatment for multivessel coronary artery disease, and to investigate adherence to prevention guidelines one year after myocardial infarction.  We used the national quality registry SWEDEHEART to collect data on long term treatment one year after myocardial infarction for 51 620 patients < 75 years of age. For 17 236 of the patients, we collected LDL-cholesterol measurements from SWEDEHEART and defined use of lipid lowering drugs from the Prescribed Drug Register. We developed a questionnaire for post-PCI-patients to investigate patients’ understanding of cause and treatment of coronary artery disease. For 23 342 PCI-patients with multivessel coronary artery disease, SWEDEHEART-data was linked to Swedish health data registries to determine one year outcome for patients undergoing incomplete vs. complete revascularization.   Lipid control (LDL-cholesterol < 1.8 mmol/L) was attained by one in four patients one year after myocardial infarction, whereas blood pressure control (< 140 mmHg) was attained by two thirds of patients. Lipid and blood pressure control was lower for women but there was no gender difference in smoking cessation rate: 56 %. Over 90 % of patients were treated with a statin after myocardial infarction but treatment was intensified for only one in five patients with LDL-cholesterol above target. The questionnaire study revealed that non-modifiable factors such as age and heredity were more often seen as cause of coronary artery disease than modifiable life style factors. Only one in five patients perceived CAD as a chronic illness, requiring life style changes. Two thirds of PCI-patients with multivessel disease underwent incomplete revascularisation, and this was associated with a twofold risk for the combination of death, myocardial infarction and repeat revascularization up to one year, compared to patients who underwent complete revascularization. We conclude that  long term treatment after myocardial infarction is suboptimal in relation to guideline recommendations. Assessment of patients’ views on CAD and better health education post PCI may facilitate life style changes. Further studies need to investigate whether complete revascularization will improve outcome for PCI-patients with multivessel disease.

Diss. (sammanfattning) Stockholm : Karol. inst., 2004. / Härtill 4 uppsatser.

CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / A terapia de reperfusÃo coronariana com angioplastia coronariana transluminal percutÃnea e colocaÃÃo de stent constitui, atualmente, o tratamento preferencial ao paciente acometido por infarto agudo do miocÃrdio. No perÃodo pÃs-angioplastia, o paciente infartado exige cuidados da equipe de enfermagem peculiares devido ao comprometimento cardÃaco e dependÃncia fÃsica. A identificaÃÃo dos diagnÃsticos de enfermagem direciona as aÃÃes de enfermagem assistidas e delegadas pelo enfermeiro. O objetivo do estudo foi analisar os diagnÃsticos de enfermagem em pacientes com infarto agudo do miocÃrdio submetidos à angioplastia transluminal percutÃnea primÃria com uso de stent coronariano. Estudo transversal de natureza descritivo-exploratÃria, realizado em um hospital pÃblico de Fortaleza-Ce. A populaÃÃo constou de 51 pacientes em seu primeiro episÃdio de infarto que realizaram angioplastia com sucesso na colocaÃÃo de stent e internados nas enfermarias cardiolÃgicas. Os dados foram coletados por meio de entrevista, exame fÃsico e consulta ao prontuÃrio do paciente durante os meses de janeiro a agosto de 2006. Os resultados mostraram predominÃncia de homens, pardos, com mÃdia de idade de 54 anos e baixa escolaridade. Identificou-se maior freqÃÃncia de infarto anterior, com artÃria descendente anterior esquerda culpada pela isquemia e classificaÃÃo de killip I. Foram encontrados, em mÃdia, 11 diagnÃsticos de enfermagem, 28 caracterÃsticas definidoras, 6 fatores relacionados e 5 fatores de risco por paciente. Os diagnÃsticos de enfermagem de maior freqÃÃncia foram: Risco de infecÃÃo, DentiÃÃo prejudicada, IntolerÃncia à atividade, DÃficits no autocuidado para banho/higiene, higiene Ãntima e vestir-se/arrumar-se, PadrÃo de sono perturbado, DeambulaÃÃo prejudicada e Mobilidade fÃsica prejudicada. A variÃvel nÃmero de diagnÃsticos apresentou associaÃÃo estatisticamente significativa com os diagnÃsticos de dÃficit no autocuidado, deambulaÃÃo e mobilidade prejudicadas. Houve associaÃÃo estatisticamente significativa entre os diagnÃsticos relacionados ao autocuidado, mobilidade e locomoÃÃo, e destes com os fatores relacionados restriÃÃes de movimentos prescritas, limitaÃÃo imposta pela retirada da bainha e estado de mobilidade prejudicada. Os dados revelaram predominÃncia de fenÃmenos relacionados à ordem biolÃgica e importÃncia na identificaÃÃo dos diagnÃsticos de enfermagem na clientela especÃfica de modo a embasar um plano de atividades de enfermagem voltadas ao atendimento das necessidades fisiolÃgicas de autocuidado e dependÃncia fÃsica. / The coronary reperfusion therapy with percutaneous transluminal coronary angioplasty and stent placement constitutes, now, the preferential treatment to the patient attacked by acute myocardial infarction. In the period after to angioplasty, the patient with infarct demands peculiar cares of the nursing team due cardiac compromising and physical dependence. The identification of the nursing diagnoses addresses the actions attended and delegated by the nurse. The objective of the study was to analyze the nursing diagnoses in patients with acute myocardial infarction submitted to the primary percutaneous transluminal coronary angioplasty with use of coronary stent. Cross sectional study of descriptive-exploratory character, accomplished in a public hospital of Fortaleza-Ce. The population consisted of 51 patients in their first infarct episode that they accomplished angioplasty with success in the placement stent and interned in the cardiac infirmaries. The data were collected by means of interview, physical exam and it consults to the recordsâ patient during the months of January to August of 2006. The results showed predominance men, brown, with average of 54 year-old age and it lowers education level. It identified high frequency of previous infarct, with artery descending previous left accused by the ischemia and Killip Classification I. They were found, on the average, 11 nursing diagnoses, 28 defining characteristics, 6 related factors and 5 risk factors for patient. The nursing diagnoses of larger frequency were: Risk for infection, Altered dentition , Activity intolerance, Bathing/hygiene self-care deficit, Toileting self-care deficit, Dressing/grooming self-care deficit, Sleep pattern disturbance, Impaired walking and Impaired physical mobility. The variable number of diagnoses presented statistic association with the diagnoses self-care deficits, Impaired walking and Impaired physical mobility. There was significant association between the diagnoses related to the self-care, mobility and locomotion, and of these with the factors related prescribed restrictions of movements, limitation imposed by the retreat of the hem and state of harmed mobility. The data revealed predominance of phenomenons related to the biological order and importance in the identification of the nursing diagnoses in the specific clientele in way to base a nursing care plan of activities returned to the attendance of the physiologic needs of self-care and physical dependence.

INTRODUÇÃO: Os suportes vasculares bioabsorvíveis (SVB) surgiram com a finalidade de aumentar a segurança tardia das intervenções coronárias percutâneas (ICP). Estes dispositivos liberam o fármaco antiproliferativo no local da obstrução e são absorvidos com o passar do tempo. A utilização do ultrassom intracoronário (USIC) pode ajudar na avaliação do processo de absorção deste dispositivo. OBJETIVOS: Primário: avaliar e comparar, pelo USIC, o volume e a área da luz, do vaso e do SVB imediatamente após o implante da prótese, e, tardiamente, aos 6 e 18 meses. Objetivos secundários: avaliar e comparar, pelo USIC, o volume e área da placa imediatamente após o implante da prótese, e, tardiamente, aos 6 e 18 meses e os diâmetros do vaso, lúmen e SVB após ICP e no seguimento. Percentual de estenose e perda tardia do lúmen pela angiografia no seguimento e incidência de eventos cardíacos adversos maiores (ECAM) até os 18 meses. MÉTODO: Trata-se de um estudo prospectivo, não randomizado com a inclusão de 20 pacientes que foram submetidos ao implante do SVB DESolve®. Foi realizado o USIC após o procedimento e aos 6 e 18 meses de seguimento. RESULTADOS: Dos 20 pacientes selecionados, um paciente recusou realizar o USCI aos 6 meses e dois não realizaram o exame aos 18 meses, sendo excluídos do estudo. Totalizando 17 pacientes analisados. A idade média foi de 58,59 ± 8,73 anos e 70,6% eram do sexo masculino. O quadro clínico predominante era de angina estável. A via de acesso preferencial foi a radial, todos os pacientes foram submetidos à pré e pós-dilatação e o sucesso angiográfico ocorreu em todos os casos. No seguimento, houve aumento significativo na área (6,41 ± 1,35 mm2 vs. 7,35 ± 1,53 mm2, p < 0,002), volume (101,19 ± 20,9 mm3 vs. 118,51 ± 26,6 mm3, p = 0,001) e diâmetros do dispositivo, pelo USIC, aos 6 meses quando comparado ao procedimento índice. Não houve alteração significativa nas áreas, nos volumes e nos diâmetros do vaso e lúmen, em qualquer comparação no seguimento. A perda tardia foi de 0,22 ± 0,30 mm aos 6 e de 0,33 ± 0,44 mm aos 18 meses. Não houve nenhum caso de reestenose angiográfica e trombose do dispositivo. No seguimento, não houve casos de ECAM. CONCLUSÕES: A ICP com a utilização do SVB DESolve® para o tratamento da doença arterial coronária não complexa demonstrou resultados promissores. Houve aumento do volume e área do dispositivo aos 6 meses e uma supressão eficaz da hiperplasia intimal sem ECAM no seguimento. / INTRODUCTION: The bioresorbable vascular scaffolds (BVS) emerged in order to increase late safety of percutaneous coronary interventions (PCI). These devices release the antiproliferative drug to the site of obstruction and are absorbed over time. The use of intravascular ultrasound (IVUS) can help in the evaluation of this device absorption process. OBJECTIVES: The primary endpoint was to evaluate and compare, through IVUS, the volume and the area of the lúmen, the vessel and the device immediately after its implantation, and later at 6 and 18 months. The secondary endpoints were to evaluate and compare, through IVUS, the volume and the area of the plaque immediately after its implantation, and later at 6 and 18 months and diameters of the vessel, lúmen and BVS after PCI and at follow-up. Percentage of stenosis and late lúmen loss by angiography and incidence of major adverse cardiac events (MACE) up to 18 months. METHOD: This is a prospective, non-randomized study, with the inclusion of 20 patients who underwent implantation of DESolveTM. IVUS was performed after the procedure and at 6 and 18 months of follow-up. RESULTS: Of the 20 patients selected, one patient refused to perform the USCI at 6 months and two did not undergo the exam at 18 months and were excluded from the study. In total, 17 patients were analyzed. The average age was 58.59 ± 8.73 years and 70,6% were male. The most common clinical presentation was stable angina. The preferred vascular acess was to radial, all patients underwent pre- and post-dilation and angiographic success occurred in all cases. At follow-up there was a significant increase in area (6,41 ± 1,35 mm2 vs. 7,35 ± 1,53 mm2, p < 0,002), volume (101,19 ± 20,9 mm3 vs. 118,51 ± 26,6 mm3, p = 0,001) and diameters of the device, by IVUS, at 6 months when compared to the index procedure. There was no significant change in the areas, volumes and diameters of the vessel and lúmen, in any comparison at follow-up. The late loss was 0,22 ± 0,30 mm at 6 and 0,33 ± 0,44 mm at 18 months. There were no cases of restenosis and scaffold thrombosis. During follow-up there was no case of MACE. CONCLUSIONS: PCI with the use of DESolve scaffold for the treatment of non-complex coronary artery disease has shown promising results. There was an increase in the volume and area of the device at 6 months and an effective suppression of intimal hyperplasia without MACE at follow-up.

Introduction: Following ST-elevation myocardial infarction (STEMI) and treatment with Primary Percutaneous Coronary Intervention (PPCI), some patients re-present with potential ischaemic heart disease (IHD) symptoms. Symptoms may be related to cardiac ischaemia, reduced psychological health or a comorbid condition, which share similar symptoms and may lead patients to seek help via acute services. The purpose of the study was to investigate the proportion of PPCI patients who re-presented to acute services due to potential IHD symptoms within 6 months of STEMI, and to explore associated factors. Methods: An explanatory mixed methods study was conducted. Quantitative data were collected at baseline and 6 months from consecutive patients attending two centres in Manchester. Variables were carefully considered based on a conceptual model for re-presentation. These included potential IHD symptom and psychological health assessments using self-report measures: the Seattle Angina Questionnaire (SAQ) and the Hospital and Anxiety and Depression Scale (HADS). Physiological health was measured using the Global Registry of Acute Coronary Events (GRACE) and the Charleson Comorbidity Index (CCI) at baseline. At 6 months re-presentation data were collected using patient records, a telephone interview and a self-report diary card. The experiences of some who re-presented (purposeful sampling) were explored through semi-structured interviews conducted at least 6 months following PPCI. Framework analysis was adopted to analyse data. Results: 202 PPCI patients returned baseline questionnaires [mean age 59.7 years (SD 13.9), 75.7% male]; 38 (18.8%; 95% CI 14.0% to 24.8%) participants re-presented due to potential IHD symptoms at 6 months; 16 (42.1%) re-presented due to a cardiac event and 22 (57.9%) did not receive a diagnosis. At both baseline and 6 months, mean HADS anxiety scores were higher for the re-presentation group compared to the non-representation group (baseline 9.5 vs 7.1, p=0.006; 6 months 9.4 vs 6.0, p<0.001). Angina symptoms were stable and infrequent at both time points for the groups. Multivariate regression modelling with the inclusion of predictors HADS anxiety, SAQ angina stability, SAQ angina frequency, GRACE and CCI, determined HADS anxiety as a predictor of re-presentation with an adjusted odds ratio of 1.12 (95% CI 1.03 to 1.22, p=0.008). The qualitative interviews with re-presenters included 25 participants (14 men, 27-79 years). Four themes were identified: fear of experiencing a further heart attack, uncertainty and inability to determine cause of symptoms, insufficient opportunity to validate self-construction of illness and difficulty adapting to life after a heart attack. Conclusion: Elevated levels of anxiety at baseline were predictive of re-presentation with potential IHD symptoms at 6 months. Factors such as shock at experiencing a heart attack, hypervigilance of symptoms and difficulty with symptom attribution appeared to play a role in raised anxiety levels for the re-presentation group. Findings suggested that changes are needed to cardiac rehabilitation and post-STEMI follow-up to address educational needs and psychological issues and changes in STEMI treatment.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第23057号 / 医博第4684号 / 新制||医||1048(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 森田 智視, 教授 湊谷 謙司, 教授 川上 浩司 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

Purpose of Review: This article reviews the latest data on unprotected left main (ULM) percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery, with a focus on the NOBLE and EXCEL trials. Recent Findings: In EXCEL trial, the primary endpoint at 3 years was 15.4% in the PCI group and 14.7% in the CABG group (p = 0.02 for non-inferiority of PCI versus CABG). In NOBLE, the primary endpoint at 5 years was 28% and 18% for PCI and CABG, respectively (HR 1.51, CI 1.13–2.0, which did not meet the criteria for non-inferiority of PCI to CABG; p for superiority of CABG was 0.0044). Higher repeat revascularization and non-procedural myocardial infarction were noted in PCI group but there was no difference in all-cause or cardiac mortality between the two groups. Summary: A heart team approach with appropriate patient selection, careful assessment of LM lesions, and meticulous procedural technique makes PCI a valid alternative to CABG for ULM stenosis.